Effect of combined training on breast cancer survivors

The effect of combined yoga and pilates training on sexual hormones, leptin, cortisol, glucose homeostasis and tumor markers on breast cancer survivors

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150531022498N34

Enrollment

Registered

2020-06-27

Start date

2020-06-29

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis (MS). Multiple sclerosis

Interventions

Intervention 1: Intervention group: 12 weeks of combined yoga and pilates training, three sessions per week, 75 minutes each session. Exercise training program consists of 10 minutes warming up, 30 m

Eligibility

Sex/Gender

Female

Age

35 Years to 50 Years

Inclusion criteria

Inclusion criteria: Ability to perform exercise training with oncologist approval underwent partial mastectomy termination of chemotherapy age between 35-50

Exclusion criteria

Exclusion criteria: More than three consecutive sessions or four intermittent sessions absence from the training injury during training

Design outcomes

Primary

Measure	Time frame
Fasting Blood Sugar. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Enzymatic method.;CA 15-3 tumor marker. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;CA 125 tumor marker. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;CEA tumor marker. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;Cortisol hormone. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;Estrogen Hormone. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;Testosterone Hormone. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;SHBG. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.	—

Measure

Time frame

Fasting Blood Sugar. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Enzymatic method.;CA 15-3 tumor marker. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;CA 125 tumor marker. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;CEA tumor marker. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;Cortisol hormone. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;Estrogen Hormone. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;Testosterone Hormone. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;SHBG. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.

—

Secondary

Measure	Time frame
HbA1C. Timepoint: Before and after the end of interventions. Method of measurement: Serum levels using Enzymatic method.;Insulin hormone. Timepoint: Before and after the end of interventions. Method of measurement: Serum levels using Eliza method.;Leptin hormon. Timepoint: Before and after the end of interventions. Method of measurement: Serum levels using Eliza method.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamane Ebrahimpour

Islamic Azad University

s99.ebrahimpour@gmail.com+98 13 4466 5179

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026